Feasibility and Pilot Efficacy of Flash-heated Breast Milk to Reduce Maternal-to-Child-Transmission of HIV in Tanzania
Flash-heat
2 other identifiers
interventional
144
1 country
1
Brief Summary
This study will investigate the feasibility of HIV positive mothers in Tanzania to correctly use the Flash-heat method to pasteurize their breast milk and for how long they are able to do so. The patients will be followed in this study for up to 3 months of Flash-heating their milk. Flash-heated breast milk could be a potential method to reduce mother-to-child transmission of HIV. The investigators will also collect infant health data to pilot a future efficacy trial. The investigators hypothesize that with enhanced home-based infant feeding counseling, mothers will be capable of Flash-heating their breast milk.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable hiv-infections
Started Mar 2008
Shorter than P25 for not_applicable hiv-infections
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 30, 2007
CompletedFirst Posted
Study publicly available on registry
August 31, 2007
CompletedStudy Start
First participant enrolled
March 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2009
CompletedFebruary 14, 2012
February 1, 2012
1.3 years
August 30, 2007
February 13, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
To determine the impact of enhanced home-based training on infant feeding outcomes.
1 year
To determine uptake (initiation and duration) of the Flash-heat method and protocol adherence by mothers in their homes.
1 year
To determine the safety of Flash-heated breast milk in a field setting.
1 year
Secondary Outcomes (1)
To pilot an efficacy trial of Flash-heat to improve infant health outcomes.
1 year
Study Arms (2)
Feasibility Study
EXPERIMENTALHIV positive women \[and a smaller number of HIV negative/unknown status (1 for every 3 infected women)\] to avoid stigmatizing home-based counseling will be recruited at 1-2 postpartum and provided enhanced home-based infant feeding counseling by community health workers to exclusively breastfeed for 6 months. Mothers will also be told about the option to Flash-heat breastmilk during and after the transition from exclusive breastfeeding. Mothers who choose to Flash-heat will be provided continued home-based counseling and support. Feasibility data will be collected during the time mothers Flash-heat.
Pilot efficacy
EXPERIMENTALWe will collect infant health data to monitor and compare health outcomes among 3 groups of infants who had exclusive breast feeding (EBF) for the first months and then either: 1) fed Flash-heated breast milk and complementary foods (n=30), or 2) weaned to replacement foods and NO breast milk (n=15; per standard WHO recommendation for rapid cessation), or 3) continued feeding at the breast and providing other foods and/or fluids, i.e. mixed feeds (n=15; per WHO consensus that breastfeeding continue if replacement feeding is not AFASS94). We will collect infant growth and morbidity data. Infant health outcomes will be compared for the 3 groups noted above. These data will be collected primarily to pilot an efficacy trial.
Interventions
Intensive infant feeding counseling which includes description and demonstration of the WHO recommended option for HIV-infected mothers to pasteurize their breastmilk. Flash-heat pasteurization will be described and demonstrated to interested mothers. More intensive counseling and support will be provided home visits.
Eligibility Criteria
You may qualify if:
- Women over the age of 18, with permanent local residence
- months post-partum
- Breastfeeding
- HIV-negative or unknown in 1:3 ratio with HIV-positive
- If HIV positive: having CD4+ \> 200, not currently on Antiretroviral Therapy (ART)
You may not qualify if:
- Males, females under the age of 18
- Women not 1-2 most postpartum
- Women not breastfeeding
- Women with HIV and CD4+ \< 200 OR on Antiretroviral Therapy (ART); And
- Women without permanent local residence
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of California, Davislead
- Thrasher Research Fundcollaborator
- University Research Co, LLCcollaborator
- California Department of Health Servicescollaborator
Study Sites (1)
University of California Davis Medical Center
Sacramento, California, 95817, United States
Related Publications (6)
Israel-Ballard K, Chantry C, Dewey K, Lonnerdal B, Sheppard H, Donovan R, Carlson J, Sage A, Abrams B. Viral, nutritional, and bacterial safety of flash-heated and pretoria-pasteurized breast milk to prevent mother-to-child transmission of HIV in resource-poor countries: a pilot study. J Acquir Immune Defic Syndr. 2005 Oct 1;40(2):175-81. doi: 10.1097/01.qai.0000178929.15904.95.
PMID: 16186735BACKGROUNDIsrael-Ballard KA, Maternowska MC, Abrams BF, Morrison P, Chitibura L, Chipato T, Chirenje ZM, Padian NS, Chantry CJ. Acceptability of heat treating breast milk to prevent mother-to-child transmission of human immunodeficiency virus in Zimbabwe: a qualitative study. J Hum Lact. 2006 Feb;22(1):48-60. doi: 10.1177/0890334405283621.
PMID: 16467287BACKGROUNDIsrael-Ballard K, Coutsoudis A, Chantry CJ, Sturm AW, Karim F, Sibeko L, Abrams B. Bacterial safety of flash-heated and unheated expressed breastmilk during storage. J Trop Pediatr. 2006 Dec;52(6):399-405. doi: 10.1093/tropej/fml043. Epub 2006 Sep 27.
PMID: 17005732BACKGROUNDChantry CJ, Abrams BF, Donovan RM, Israel-Ballard KA, Sheppard HW. Breast milk pasteurization: appropriate assays to detect HIV inactivation. Infect Dis Obstet Gynecol. 2006;2006:95938. doi: 10.1155/IDOG/2006/95938. No abstract available.
PMID: 17093357BACKGROUNDIsrael-Ballard K, Donovan R, Chantry C, Coutsoudis A, Sheppard H, Sibeko L, Abrams B. Flash-heat inactivation of HIV-1 in human milk: a potential method to reduce postnatal transmission in developing countries. J Acquir Immune Defic Syndr. 2007 Jul 1;45(3):318-23. doi: 10.1097/QAI.0b013e318074eeca.
PMID: 17514015BACKGROUNDIsrael-Ballard KA, Abrams BF, Coutsoudis A, Sibeko LN, Cheryk LA, Chantry CJ. Vitamin content of breast milk from HIV-1-infected mothers before and after flash-heat treatment. J Acquir Immune Defic Syndr. 2008 Aug 1;48(4):444-9. doi: 10.1097/QAI.0b013e31817beb8d.
PMID: 18614920BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Caroline J Chantry, MD
University of California, Davis
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 30, 2007
First Posted
August 31, 2007
Study Start
March 1, 2008
Primary Completion
July 1, 2009
Study Completion
July 1, 2009
Last Updated
February 14, 2012
Record last verified: 2012-02